Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CONCORD DRUGS Share Price   (CODL)



Here is the latest stock price and chart of CONCORD DRUGS. For more details, see the CONCORD DRUGS company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Must See: Do You Invest in Midcap Stocks? Here's a Great News for You

REFRESH
Live BSE Quotes Apr 16, 2024 (Close)
Price (Rs)36.62 Open (Rs) 36.37 High (Rs) 37.74 Low (Rs) 36.37
% Change0.69 Volume 9,015 Value (Rs) 334,754 52-Week H/L 61.50 / 25.56
Live NSE Quotes
Not listed
Change
1 Day
0.69%
1 Month
-3.83%
3 Months
-14.92%
1 Year
20.30%
5 Years (CAGR)*
10.88%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 0.98 P/E Ratio (x) 37.52 Market Cap (Rs m) 366.20 P/BV (x) 1.04 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

CONCORD DRUGS Share Price Today:

CONCORD DRUGS last traded price was up 0.7% to Rs 36.6 on the BSE. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.4%. And the benchmark S&P BSE SENSEX was at 72,943.7 (down 0.6%).

Over the last 30 days, the CONCORD DRUGS share price is down 3.0%. And over the last one year, CONCORD DRUGS share price is up 20.3%.

The current market capitalisation of CONCORD DRUGS stands at Rs 366.20 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of December 2023, company promoters held 55.41% stake in CONCORD DRUGS, with no shares having been pledged. To know more, check out the latest shareholding pattern of CONCORD DRUGS.



FAQs on CONCORD DRUGS

What is the CONCORD DRUGS share price today?

The last traded price of CONCORD DRUGS was Rs 36.6 on the BSE, up 0.7% over the previous close.

What is the market cap of CONCORD DRUGS?

The current market capitalisation of CONCORD DRUGS stands at Rs 366 m.

What is the Earnings per share (EPS) of CONCORD DRUGS?

CONCORD DRUGS had an EPS of Rs 1.0 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs -0.2.

What is the PE Ratio and PB Ratio of CONCORD DRUGS?

At the current price of Rs 36.6, CONCORD DRUGS trades at a PE ratio of 37.52 while its PB ratio stands at 1.04.

What is the Dividend Yield of CONCORD DRUGS?

For the financial year 2023, CONCORD DRUGS declared dividend amounting to Rs 0.0 per share. At the current price of Rs 36.6, this results in a dividend yield of 0.0%.

Which are the top pharmaceuticals companies in India by marketcap?

Based on marketcap, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks ranked by marketcap here.

Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.

Which are the biggest pharmaceuticals companies in India by sales?

Based on sales, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.

Which are the biggest pharmaceuticals companies in India by net profit?

Based on net profit, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.


Today's Market

Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today(Pre-Open)

Indian share markets Slipped further as the session progressed and ended the day weak.